| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | SVP, Head Of Finance &Admin. | See Remarks
2 companies
Scalzo Richard William is a SVP, Head Of Finance &Admin. at Dyne Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 18 sells.
Estimated insider holdings value: $2.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2024 | DYN Dyne Therapeutics, Inc. | SVP, Head Of Finance &Admin. | Sell | 2,588 | $28.27 | $73,161.78 | -1.1% | +52.6% | -58.9% | |
| Mar 11, 2024 | DYN Dyne Therapeutics, Inc. | SVP, Head Of Finance &Admin. | Sale+OE | 88,924 | $26.19 | $2,329,006.68 | -11.8% | +23.3% | -52.9% | |
| Mar 7, 2024 | DYN Dyne Therapeutics, Inc. | SVP, Head Of Finance &Admin. | Sell | 2,273 | $25.85 | $58,757.05 | -1.8% | +24.4% | -53.1% | |
| Mar 1, 2024 | DYN Dyne Therapeutics, Inc. | SVP, Head Of Finance &Admin. | Sale+OE | 12,740 | $28.05 | $357,296.44 | -3.3% | +7.1% | -53.3% | |
| Jan 26, 2024 | DYN Dyne Therapeutics, Inc. | SVP, Head Of Finance &Admin. | Sale+OE | 13,000 | $24.34 | $316,420.00 | -9.5% | +12.0% | -35.2% | |
| Jan 3, 2024 | DYN Dyne Therapeutics, Inc. | SVP, Head Of Finance &Admin. | Sale+OE | 13,000 | $18.81 | $244,530.00 | -9.5% | +88.5% | +72.4% | |
| Dec 14, 2023 | DYN Dyne Therapeutics, Inc. | See Remarks | Sell | 2,376 | $12.02 | $28,559.52 | -1.9% | +134.9% | +117.7% | |
| Dec 11, 2023 | DYN Dyne Therapeutics, Inc. | See Remarks | Sell | 1,380 | $10.72 | $14,793.60 | -1.1% | +134.4% | +159.9% | |
| Dec 6, 2023 | DYN Dyne Therapeutics, Inc. | See Remarks | Sell | 2,553 | $12.01 | $30,661.53 | -1.0% | +126.5% | +142.9% | |
| Sep 18, 2023 | DYN Dyne Therapeutics, Inc. | See Remarks | Sell | 1,290 | $9.41 | $12,138.90 | -3.1% | +21.1% | +251.3% |